{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-25-000118","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.156340+00:00","generated_at":"2026-05-16T15:57:41.696620+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Encompass Health reaffirms full-year 2025 guidance ahead of investor meetings","bullets":["Net operating revenue expected $5,905M to $5,955M.","Adjusted EBITDA guidance range of $1,235M to $1,255M.","Adjusted EPS from continuing ops attributed to Encompass Health: $5.22 to $5.37.","Management to meet investors December 2–3, 2025; guidance unchanged from Oct 29, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-25-000118","json":"https://secwatch.observer/filing/0000785161-25-000118.json","markdown":"https://secwatch.observer/filing/0000785161-25-000118.md","text":"https://secwatch.observer/filing/0000785161-25-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000118/0000785161-25-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000118/ehc-20251201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:57:41.696620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}